Skip to main content
PLOS One logoLink to PLOS One
. 2018 Sep 11;13(9):e0203487. doi: 10.1371/journal.pone.0203487

Heart rate variability as predictor of mortality in sepsis: A systematic review

Fábio M de Castilho 1,*, Antonio Luiz P Ribeiro 1, Vandack Nobre 1,2, Guilherme Barros 1, Marcos R de Sousa 1
Editor: Andrea Cortegiani3
PMCID: PMC6133362  PMID: 30204803

Abstract

Background

Autonomic dysregulation is one of the recognized pathophysiological mechanisms in sepsis, generating the hypothesis that heart rate variability (HRV) can be used to predict mortality in sepsis.

Methods

This was a systematic review of studies evaluating HRV as a predictor of death in patients with sepsis. The search was performed by independent researchers in PubMed, LILACS and Cochrane, including papers in English, Portuguese or Spanish, indexed until August 20th, 2017 with at least 10 patients. Study quality was assessed by Newcastle-Ottawa Scale. To analyze the results, we divided the articles between those who measured HRV for short-term recordings (≤ 1 hour), and those who did long-term recordings (≥ 24 hours).

Results

Nine studies were included with a total of 536 patients. All of them were observational studies. Studies quality varied from 4 to 7 stars in Newcastle-Ottawa Scale. The mortality rate in the studies ranged from 8 to 61%. Seven studies performed HRV analysis in short-term recordings. With the exception of one study that did not explain which group had the lowest results, all other studies showed reduction of several HRV parameters in the non-survivors in relation to the surviving septic patients. SDNN (Standard deviation of the Normal to Normal interval), TP (Total Power), VLF (Very Low Frequency Power), LF (Low Frequency Power), LF/HF (Low Frequency Power / High Frequency Power), nLF (Normalized Low Frequency Power), α1/α2 (short-term and long-term fractal scaling coefficients from DFA) and r-MSSD (Square root of the squared mean of the difference of successive NN-intervals) of the non-survivor group were reduced in relation to the survivors in at least one study. Two studies found that SDNN is associated with mortality in sepsis, even after adjusting for possible confounding factors. Three studies performed HRV analysis using long-term recordings. Only one of these studies found difference between surviving and non-surviving groups, and even so, in only one HRV parameter: LogHF.

Conclusions

Several HRV parameters are reduced in nonsurviving septic patients in short-term recording. Two studies have found that SDNN is associated with mortality in sepsis, even after adjusting for possible confounding factors.

Introduction

Sepsis, a syndrome in which there is dysregulated host response to infection and presence of organ dysfunction[1], has a high mortality rate that can vary between 10 and 50%[1, 2]. In addition to high lethality, its incidence has increased significantly in recent decades, making sepsis a serious global health problem [3]. For all these reasons, it is useful to identify the most serious septic patients through predictive scoring systems. Although autonomic dysregulation is one of the recognized pathophysiological mechanisms in sepsis[4], existing predictive scoring systems such as APACHE II (Acute Physiology and Chronic Health disease Classification System II)[5], SOFA (Sepsis-related Organ Failure Assessment)[6], SAPS-3 (Simplified Acute Physiology Score III)[7, 8] and MODS (Multiple Organ Dysfunction Score)[9] do not considers in their composition changes in the autonomic nervous modulation.

Physiological variation of heart rate indicates heart's capacity to adapt to different situations, and is influenced, among other factors, by the autonomic nervous system [10]. Heart rate variability (HRV) measures oscillations of the intervals between consecutive heart beats, being therefore a noninvasive indirect test to evaluate autonomic function [11]. Studies have shown that patients with sepsis have reduced HRV compared to healthy patients[12, 13]. Ahmad et al. demonstrated, in a small study, that patients with sepsis showed a significant drop in the value of several HRV parameters on average 35 hours before the diagnosis of sepsis[14]. These findings raised the possibility that the HRV can be used to predict the risk of developing sepsis or even for the diagnosis of sepsis. In addition to the diagnosis of sepsis, HRV parameter reduction seems to be related to worse outcomes in septic patients, and has a correlation with APACHE II and SOFA[15]. Finally, some studies have shown that HRV can be used to predict the risk of septic patients develop septic shock [16] and multiple organ dysfunction[17]. Recently, our research group published the results of a cohort study with septic patients in which several parameters of HRV were reduced in those patients who died in comparison to their counterparts. [18].

The objective of this study was to perform a systematic review of studies evaluating HRV as a predictor of death in patients with sepsis.

Materials and methods

Following the PRISMA statement [19] for systematic reviews and specific guidelines for nonrandomized studies [20], three bibliographic methods were used to identify potential abstracts or investigations: remote search in electronic databases; evaluation of bibliographic citations from hand search of texts; and email contact with authors (see S1 File for PRISMA Checklist and S2 File for PRISMA Flow Diagram). The databases used were PubMed, LILACS and Cochrane. Independent reviewers participated in the search and selection of studies. Two independent reviewers (FMC and GB) made the search and selection of studies in the databases, while MRS resolved any divergences. Additional articles were searched by citation tracking of review articles and original articles, and by looking for additional articles authored by the same authors of the papers previously selected. After analyzing titles and abstracts, the selected articles were read in full to confirm eligibility, and doubts or disagreements were solved through discussions with senior researchers (ALPR, VN and MRS). Inclusion criteria were clearly defined before the beginning of search. This systematic review has been registered within PROSPERO (the NIHR International Prospective Register of Systematic Reviews), under the registration number CRD42017062367.

We included studies containing more than 10 patients which evaluated heart rate variability as predictor of mortality in sepsis, published before August 20th, 2017. Review studies and case series were excluded from this review. Publication languages included English, Portuguese and Spanish. The search-terms used were: "("Systemic Inflammatory Response Syndrome"[Mesh] OR "Systemic Inflammatory Response Syndrome" [All Fields] OR "Sepsis"[Mesh] OR "sepsis"[All Fields]) AND (("heart rate"[MeSH Terms] OR heart rate[Text Word]) AND (variability[Text Word] OR turbulence[All Fields]) OR "Nonlinear Dynamics"[Mesh] OR "Entropy"[Mesh] OR “triangular index”) AND (incidence[MeSH] OR mortality[MeSH] OR follow-up studies[MeSH] OR prognos*[Text Word] OR predict*[Text Word] OR course*[Text Word])”. Besides textual and MeSH terms selection, hand search within each paper’s references, and also "related citations", a search tool available in PubMed, were used to increase sensitivity of the search.

Two researchers (MRS and FMC) independently double checked the extraction of primary data from each study. Discrepancies were solved by consensus after discussion with the remaining researchers. The following information was extracted: study design and methodological data; demographic and clinical characteristics of patients; number of patients who died and mean or median values of each HRV parameter in the surviving and non-surviving groups.

The Newcastle-Ottawa Scale[21] was used to assess the quality of the included studies. Using this 'star system' (ranges from 0 to 9) each included study was judged on three broad perspectives, as recommended by the Cochrane Non-Randomized Studies Methods Working Group Version 5.1.0 [20, 22]: the selection of the study groups; the comparability of the groups; and the ascertainment of outcome of interest.

To analyze the results, we divided the articles between those who measured HRV for short-term recordings (≤ 1 hour), and those who did long-term recordings (≥ 24 hours), since we know that long-term recording have different oscillatory components as compared to those of short duration[11].

One of the included studies contained the median value of SDNN for surviving and non-surviving groups, but did not report the p-value of the comparison between groups. So, we estimated the mean and standard deviation of SDNN of each group on basis of the sample’s reported median and range according to the method devised by S.P. Hozo, B. Djulbegovic, and I. Hozo[23]. Subsequently, SDNN of survivors and nonsurvivors were compared using the Student´s t test, conducted in SPSS version 23 (SPSS Inc., Chicago, IL, USA).

Results

The selection process and the inclusion flow of studies are shown in Fig 1. Nine studies were included, with a total of 536 patients [18, 2431]. Table 1 shows the main methodological characteristics of the studies, and Table 2 reported the rate for each item of the Newcastle-Ottawa Scale, while Table 3 describes the methodologies used in each study to measure HRV.

Fig 1. Inclusion flow of studies.

Fig 1

Table 1. Characteristics of included studies.

Study
(1st author/year)
Country Enrollment
period
Sample Size Age
(Mean)
Male
(%)
Mortality Endpoint Mortality Rate (%) Definition of sepsis Population (Septic patients) Exclusion criteria
Tateishi 2007 China 2002 to 2005 45 54 71 ? 29 Infectious SIRS Adults in the ICU DM or neurological disease
Nogueira 2008 Brasil 2003 to 2005 31 51 74 In-hospital mortality 61 Infectious SIRS Adults in the ICU receiving mechanical ventilation MI, nonsinusal rhythm, use of a permanent pacemaker, CHF class III or IV, or DM
Chen 2008 Taiwan 2006 132 67 47 In-hospital mortality 8 Infectious SIRS Adults in the ED Arrhythmia, cardiac pacing or respiratory failure under mechanical ventilator
Papaioannou 2009 Greece 2007 to 2008 20 58 76 ? 20 ? Adults in the ICU receiving mechanical ventilation Atrial flutter or fibrillation, ventricular ectopic beats, use of anti-arrhythmic medication, severe brain injuries or acquired immunodeficiencies
Duque 2012 Colombia 2009 to 2010 100 55 58 ? 40 ? Adults in the ICU with the need for cardiovascular or ventilatory support Clinical or electrocardioggraphic features complicating interpretation of the Holter recordings or coronary disease
Chen 2012 Taiwan ? 64 ? ? 24-hour mortality 25 Infectious SIRS Age- and sex-matched patients with sepsis in the ED used as the negative controls Persistent arrhythmia or cardiac pacing
Brown 2013 USA 2009 to 2011 48 57 46 28-day mortality 10 Infectious SIRS >15 years of age patients in the ICU with severe sepsis or septic shock Pregnancy or non-sinus rhythm
Cedillo 2015 Spain 2012 33 62 39 In-hospital mortality 18 Infectious SIRS Non-smoking patients admitted to the ward Malignant diseases, CHF, nonsinusal rhythm, COPD, immunosuppression, use of beta or calcium-channel blockers, poorly-controlled DM, liver or renal failure or age > 80 years.
Castilho 2017 Brasil 2012 to 2014 63 53 60 28-day mortality 25 Infectious SIRS Adults in the ICU Antibiotic therapy for more than 48 hours prior to enrollment, nonsinus rhythm or with pacemaker

ICU = Intensive Care Unit; SIRS = Systemic Inflammatory Response Syndrome; ED = Emergency Department; DM = diabetes mellitus; MI = myocardial infarction; CHF = chronic heart failure; COPD = chronic obstructive pulmonary disease

Table 2. Newcastle-Ottawa Scale.

Study
(1st author/year)
Selection 1 Selection 2 Selection 3 Selection 4 Comparability Outcome 1 Outcome 2 Outcome 3 Total Score
Tateishi 2007 0 1 1 1 0 1 0 1 5
Nogueira 2008 0 1 1 1 0 1 1 1 6
Chen 2008 1 1 1 1 0 1 1 1 7
Papaioannou 2009 1 1 0 1 0 1 0 0 4
Duque 2012 1 1 1 1 0 1 1 0 6
Chen 2012 0 1 1 1 0 1 0 1 5
Brown 2013 1 1 1 1 0 1 1 1 7
Cedillo 2015 0 1 0 1 0 1 1 0 4
Castilho 2017 1 1 1 1 0 1 1 1 7

Table 3. HRV measurement in included studies.

Study
(1st author/year)
Duration of measurement Recording period used for analysis Equipment Recording day Patient´s conditions during record Were there patients receiving Mechanical Ventilation? HRV parameters
Tateishi 2007 24-hour 24-hour Monitor First and last ? Yes Frequency domain: LF, HF
Nogueira 2008 30-minute ? Holter 1,3 and 6 Supine position, with ventilatory parameters completely controlled by the ventilator All Frequency domain: LF, HF, LF/HF
Chen 2008 10-minute The last 512 R-R intervals ECG First Supine position, room temperature around 25°C No Time domain: SDNN, r-MSSD; Frequency domain: TP, VLF, LF, HF, nVLF, nLF, nHF and LF/HF
Papaioannou 2009 10-minute 128 seconds time serie Holter ? Supine position All Time domain: SDNN; Frequency domain: LF, HF, LF/HF; Nonlinear method: SD1/SD2
Duque 2012 48-hour ? Holter First ? Yes Time domain: SDNN, pNN50
Chen 2012 10-minute The last 512 R-R intervals ECG First ? Yes Time domain: SDNN, CV; Frequency domain: TP, VLF, LF, HF, LF/HF
Brown 2013 6-hour First 30minutes Monitor First ? Yes Time domain: NN, SDNN, r-MSSD, pNN50, NN50; Frequency domain: TP, LF, HF, LF/HF; Nonlinear methods: SD1/SD2, Sample entropy, DFA short-term coefficient, DFA long-term coefficient, Ratio of DFA coefficients
Cedillo 2015 15-minute The last 512 R-R intervals ECG First Supine position after a 10-min resting period and normal breathing No Time domain: r-MSSD; Frequency domain: TP, LF, HF, LF/HF
Castilho 2017 20-minute and 24-hour First 10 minutes Holter First Supine position and no intervention was made during its recording Yes Time domain: NN, SDNN, r-MSSD, pNN50; Frequency domain: TP, VLF, LF, HF, LF/HF

LF = Low Frequency Power; HF = High Frequency Power; LF/HF = Low Frequency Power / High Frequency Power; TP = Total Power; VLF = Very Low Frequency Power; nVLF = Normalized Very Low Frequency; nLF = Normalized Low Frequency Power; nHF = Normalized High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval; r-MSSD = Square root of the squared mean of the difference of successive NN-intervals; pNN50 = Percentage of NN intervals deviated by more than 50 ms from adjacent NN-intervals; NN50 = Number of pairs of adjacent NN intervals differing by more than 50 ms in the entire recording; SD1 = Poincare standard deviation 1; SD2 = Poincare standard deviation 2; DFA = Detrended Fluctuation Analysis; CV = Coefficient of variation

Study quality analysis by the Newcastle-Ottawa Scale showed that, in general, studies were representative of the sampled population, varying from 4 to 7 stars (mean 5.7). Except for the study of Chen and cols. 2012[27], in which patients with sepsis were included as controls of successfully resuscitated patients with out-of-hospital cardiac arrest (the main population of interest in the study), all other studies were prospective cohorts primary designed to include/primary focused on septic patients. One of the studies[25] was a combined prospective cohort and case-control study. The cohort group consisted of 33 septic patients, and these were the data we used in this review. Regarding the diagnostic criteria for sepsis used in each study, in two studies[28, 30] this information is not clearly reported, while in the other 7 studies[18, 2427, 29, 31] the presence of infection and SIRS was used as the diagnostic criteria. Of these seven studies, two[24, 31] use the 1992 Consensus[32], while five[18, 2527, 29] use the 2001 consensus[33].

Taken as whole, the included studies measured the following HRV parameters in the time domain: Normal-to-Normal (NN) average interval, Standard deviation of the NN interval (SDNN), Square root of the squared mean of the difference of successive NN-intervals (r-MSSD), Percentage of NN intervals deviated by more than 50 ms from adjacent NN-intervals (pNN50), Number of pairs of adjacent NN intervals differing by more than 50 ms in the entire recording (NN50), Coefficient of variation (CV); frequency domain: Low Frequency Power (LF), High Frequency Power (HF), ratio of LF to HF (LF/HF), Total Power (TP), Very Low Frequency Power (VLF), Normalized Very Low Frequency (nVLF), Normalized Low Frequency Power (nLF) and Normalized High Frequency Power (nLF); nonlinear methods: Poincare standard deviation 1 (SD1), Poincare standard deviation 2 (SD2), Short-term (α1) and long-term (α2) fractal scaling coefficients from Detrended Fluctuation Analysis (DFA).

Of the nine studies included in this systematic review, five make explicit the realization of some type of treatment for artifacts (period selection without artifact, manual deletion of artifacts, deletion of record if it presents artifact percentage greater than a predetermined value etc.). The way this was done in each study can be seen in the S1 Table.

The small number of studies, their technical limitations and its great heterogeneity prevented a meta-analysis to be performed. Some studies only presented HRV results in graphs [29, 31] or summary descriptions in the body of the article[24, 25, 30], without informing the central value of each HRV parameter in the surviving and non-surviving groups. The outcome of one study was 24-hour mortality[27], not allowing comparison with the other studies, which assessed mortality at longer time interval: 28-day mortality in two studies[18, 24], the in-hospital mortality in three studies[25, 26, 29] and, although the time at which endpoint mortality is assessed is unclear in the remaining three studies[28, 30, 31], the presented data strongly suggest that the follow-up for this outcome was longer than 24h, probably being in-ICU mortality. There was also a large difference in the population evaluated in the included studies: for instance, while two of the studies excluded mechanically ventilated patients[25, 26], two other studies restricted their analysis to patients who were on mechanical ventilation[29, 30]. The mortality rate observed in the different studies varied considerably, ranging from 8 to 61%, probably indicating a difference in clinical spectrum among populations.

Seven studies performed HRV analysis in short-term recordings (≤ 1 hour) [18, 2427, 29, 30], Three studies performed HRV analysis using long-term recordings (≥ 24 hours) [18, 28, 31]. One of the articles [24] did an intermediate period recording (6 hours), but in this paper HRV analysis was restricted to the first 30 minutes of recording. Therefore, this study was included in the short-term recording (<1 hour) group. We did not find any article that did HRV analysis for period between 1 hour and 24 hours. The main results of these studies are presented in Table 4 and Table 5, respectively. One of the studies made both a recording of short duration (20 minutes) and another one of long duration (24 hours)[18].

Table 4. Main results in short time record studies.

Study
(1st author/year)
Duration of measurement Does it show the values (mean or median) of HRV parameters in the surviving and non-survivors groups? How are the results presented? HRV parameters of nonsurvivors lower than those of survivors* HRV parameters of nonsurvivors higher than those of survivors* Additional results / Comments
Nogueira 2008 30-minute No Graph comparing LF, HF e LF/HF between surviving and non-surviving patients. LF, HF and LF/HF
Chen 2008 10-minute Yes Table with HRV parameters values for surviving and non-surviving groups SDNN, TP, VLF, LF and LF/HF nHF Multiple logistic regression model identified SDNN and nHF as the significant independent variables in the prediction mortality.
Papaioannou 2009 10-minute No Only citation in the text of the article The natural logarithms of SDNN, LF and HF were significantly different between survivors and non-survivors, but there is no information on which patient group had the highest values.
Chen 2012 10-minute Yes Table with HRV parameters values for surviving and non-surviving groups nLF, and LF/HF nHF and HF
Brown 2013 30-minute No Only citation in the text of the article α1/α2
Cedillo 2015 15-minute No Only citation in the text of the article r-MSSD and nHF
Castilho 2017 20-minute Yes Table with HRV parameters values for surviving and non-surviving groups SDNN, TP, VLF, LF and LF/HF SDNN ≤17 is a risk factor for death in septic patients, even after adjusting for APACHE II or SOFA.

* = Only results with statistical significance were shown

LF = Low Frequency Power; HF = High Frequency Power; LF/HF = Low Frequency Power / High Frequency Power; TP = Total Power; VLF = Very Low Frequency Power; nLF = Normalized Low Frequency Power; nHF = Normalized High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval; r-MSSD = Square root of the squared mean of the difference of successive NN-intervals; DFA = Detrended Fluctuation Analysis; CV = Coefficient of variation; α1/α2 = short-term and long-term fractal scaling coefficients from DFA

Table 5. Main results in long time record studies.

Study
(1st author/year)
Duration of measurement Does it show the values of HRV parameters in the surviving and non-survivors groups? How are the results presented? HRV parameters of nonsurvivors lower than those of survivors* HRV parameters of nonsurvivors higher than those of survivors* Additional results / Comments
Tateishi 2007 24-hour No Graph comparing logLF and logHF between surviving and non-surviving patients LogHF
Duque 2012 48-hour Yes Table with SDNN and PNN50 values for surviving and non-surviving groups
Median SDNN non significantly higher in the surviving group than in the nonsurvivor group (72.5ms [IQR 42] vs 61ms [IQR 65],p value not reported in the article, but we calculated p = 0.272)
Castilho 2017 24-hour Yes Table with HRV parameters values for surviving and non-surviving groups There was no statistically significant difference in any HRV parameter measured in the 24 hours Holter between the two subgroups

* = Only results with statistical significance were shown

Log = logarithm; LF = Low Frequency Power; HF = High Frequency Power; NN = Normal-to-Normal average interval; SDNN = Standard deviation of the NN interval

Regarding the studies that used short term recordings to measure HRV, one of them reported a statistically significant difference of SDNN, LF and HF values between survivors and non-survivors, but authors did not inform which patient group had the highest values, what does not allow a deeper analysis of these results and comparison with other studies[30]. The remaining studies (n = 6) showed reduction of several HRV parameters in the non-survivors in relation to the surviving septic patients: SDNN[18, 26], TP[18, 26], VLF[18, 26], LF[18, 26, 29], LF/HF ratio[18, 26, 27, 29], nLF[27], α1/α2[24] and r-MSSD[25]. From these studies, four did not show the exact central value (mean or median) of the HRV parameters in survivor and non-survivor groups, presenting the results only in graphics or summarized in the body of the article. Chen et al, through the multiple logistic regression model, found that SDNN was a significant independent variable in the prediction of mortality in sepsis, with odds ratio of 0.719 (0.537–0.962), p = 0.026 [26]. Castilho et al defined a cut-off point for the SDNN of 17ms and found that Cox regression for dichotomous SDNN adjusted by the APACHE II showed Hazard ratio (HR) of 5.5 (1.2±24.8; p = 0.027) and Cox regression for this dichotomous variable adjusted by the SOFA showed HR of 6.3 (1.4±28.0; p = 0.015) [18].

There was a contradiction in the outcome prediction of HF and nHF, where some studies showed that their values were reduced in the non-survivor group [25, 29], while other studies showed higher values of these parameters were in the same group [26, 27].

From the studies using long-term recordings, only one article found statistically significant differences of any HRV parameter between survivors and non-survivors: LogHF was higher in the non-survivor than the survivor group[31]. The other two articles found no statistically significant differences between survivors and non-survivors for any HRV parameter[18, 28].

Discussion

In this systematic review, we found that HRV parameters measured in short-term recordings were reduced in septic patients who died in relation to those who survived. This finding raises the possibility that HRV measurement can be a useful tool to predict the risk death in sepsis. On the other hand, there was no clear evidence of association between HVR parameters in long-term recordings and sepsis outcome.

There have has been an increasing interest in the role played by the autonomic nervous system in the complexes mechanisms involved in sepsis physiopathology. It is known, for example, that vagus nerve stimulation increases the secretion of corticotropin-releasing hormone, ACTH and cortisol[34]; it has been demonstrated that vagotomy attenuates fever response[35]; and that acetylcholine, the main vagal neurotransmitter, has an anti-inflammatory effect, attenuating the release of cytokines such as TNF, IL-1beta, IL-6 and IL-18, and preventing the development of shock[36]. Taken together, these findings suggest that the autonomic nervous system is involved in peripheral cytokine-to-brain communication, participating in the pathophysiology of sepsis.

Based on these results, some authors have investigated if the measurement of HRV, a noninvasive indirect test to evaluate autonomic function, in septic patients could be useful to predict outcome in these patients. HRV is measured using simple and non-invasive methods, requiring automated devices available on the market. Therefore, HRV is considered one of the most popular methods used to evaluate the autonomic function, being suitable for use in emergency department, ward or intensive care settings, where septic patients are usually taken[11].

The seven studies that analyzed HRV in short-term recordings[18, 2427, 29, 30] showed significant difference between groups of surviving and non-surviving septic patients regarding different parameters. Except for one study that did not report which group had the highest value[30], the other six studies showed a reduction of at least one HRV parameter in the group of patients who died. These findings suggest that loss of heart rate oscillatory capacity, controlled, among other factors, by the autonomic nervous system is related to the severity of sepsis and risk of death. The only conflicting results revealed by this systematic review referred to the HF Power, which was shown to be reduced in the non-survivor group in some studies, but increased in others. HF Power reflects the vagal activity (parasympathetic) on the sinus node[37]. Different factors could explain the conflicting results for HF Power, such as the fact that the studies have small samples, the heterogeneity of the populations (some only with patients on mechanical ventilation, others only with patients on spontaneous ventilation, for example) or the presence of artifacts in electrocardiographic records. Of the nine studies included in this systematic review, five make explicit the realization of some type of treatment for artifacts. Studies show that the presence of artifacts or different treatment given to them may inflate the HRV analysis result[38, 39].

Among all HRV parameters tested to predict risk of death in sepsis, several parameters in both time domain and frequency domain have been shown to be reduced in non-surviving septic patients. More studies are needed to define which HRV parameters are most useful to predict mortality in sepsis and which cut-off values of each parameter should be used. [18, 26, 27, 29][18, 26]However, the SDNN stands out in the studies carried out until now, because two studies found this parameter as being associated with sepsis mortality, even after adjusting for possible confounding factors[18, 26] and one of these studies have even tested a cut-off point for this parameter[18]. SDNN seems to reflect all the cyclic components responsible for HRV (including sympathetic and parasympathetic activity)[11]. Some studies used the ICU monitors themselves to perform the electrocardiographic recording[24, 31], assuming that, through the implementation of SDNN calculation software, the ICU monitors themselves could calculate the SDNN of septic patients as a measure of the risk of death.

Only one [31] from the three [18, 28, 31] studies that analyzed long-term recordings for HRV found differences between surviving and non-surviving groups, and even so, in only one HRV parameter. We believe that the difficulty of association between HRV parameters and mortality in sepsis in long-term recordings is due, among other factors, to the dynamic condition of sepsis, in which metabolic disturbances, hemodynamic and ventilatory evolutionmay interfere with HRV parameters. In short-term recordings, it is possible to keep the patient in a specific position (supine, for example) and keep the patient without interventions such as orotracheal aspiration, which could interfere with HRV. Furthermore, in critical care patients, shorter periods of recording minimizes the interference with ICU routine activities, and have the advantage of being a fast tool for definition of severity, as these patients present immediate risk of death.

Study limitations

The main limitation of this systematic review is the low number and quality of the studies included. The great heterogeneity of the HRV recording and analysis methods used, as well as the great heterogeneity of the population of each study prevented us to perform a meta-analysis. Other limitations are the low number of patients in each study and the fact that all of them were unicentric. Thus, although it is possible to affirm that a reduction in HRV fall seems to be related to sepsis mortality, it would be necessary to perform a larger, preferably multicenter study, to define the best HVR recordings and analysis methodology, as well as what parameters and cutoff points should be adopted to predict the risk of death.

Conclusions

Several HRV parameters are reduced in nonsurviving septic patients in short-term recording. SDNN seems to be independently associated with mortality in sepsis, emerging as a useful HRV parameter to predict sepsis outcome. These findings need to be confirmed in larger well-designed studies.

Supporting information

S1 File. PRISMA checklist.

(DOC)

S2 File. PRISMA flow diagram.

(DOC)

S1 Table. Treatment for artifacts used in each study.

(DOC)

Acknowledgments

The authors thank the Pro-Rectory of Research of UFMG for their support.

Data Availability

All files are available from the Open Science framework database (https://osf.io/czq6k/).

Funding Statement

This study received financial support from the Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG http://www.fapemig.br, Foundation for the Support of Research in the state of Minas Gerais - APQ04713-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):801–10. Epub 2016/02/24. 10.1001/jama.2016.0287 ; PubMed Central PMCID: PMC4968574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pavon A, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, et al. Profile of the risk of death after septic shock in the present era: an epidemiologic study. Crit Care Med. 2013;41(11):2600–9. Epub 2013/08/22. 10.1097/CCM.0b013e31829a6e89 . [DOI] [PubMed] [Google Scholar]
  • 3.Walkey AJ, Wiener RS, Lindenauer PK. Utilization patterns and outcomes associated with central venous catheter in septic shock: a population-based study. Crit Care Med. 2013;41(6):1450–7. Epub 2013/03/20. 10.1097/CCM.0b013e31827caa89 ; PubMed Central PMCID: PMC3780984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zaky A, Deem S, Bendjelid K, Treggiari MM. Characterization of cardiac dysfunction in sepsis: an ongoing challenge. Shock. 2014;41(1):12–24. Epub 2013/12/20. 10.1097/SHK.0000000000000065 . [DOI] [PubMed] [Google Scholar]
  • 5.Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–29. Epub 1985/10/01. . [PubMed] [Google Scholar]
  • 6.Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10. Epub 1996/07/01. . [DOI] [PubMed] [Google Scholar]
  • 7.Metnitz PG, Moreno RP, Almeida E, Jordan B, Bauer P, Campos RA, et al. SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description. Intensive Care Med. 2005;31(10):1336–44. Epub 2005/09/01. 10.1007/s00134-005-2762-6 ; PubMed Central PMCID: PMC1315314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, et al. SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31(10):1345–55. Epub 2005/09/01. 10.1007/s00134-005-2763-5 ; PubMed Central PMCID: PMC1315315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638–52. Epub 1995/10/01. . [DOI] [PubMed] [Google Scholar]
  • 10.Vanderlei LC, Pastre CM, Hoshi RA, Carvalho TD, Godoy MF. Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc. 2009;24(2):205–17. Epub 2009/09/22. . [DOI] [PubMed] [Google Scholar]
  • 11.Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93(5):1043–65. Epub 1996/03/01. . [PubMed] [Google Scholar]
  • 12.Aboab J, Polito A, Orlikowski D, Sharshar T, Castel M, Annane D. Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach. Crit Care Med. 2008;36(5):1481–6. Epub 2008/04/25. 10.1097/CCM.0b013e31816f48f2 . [DOI] [PubMed] [Google Scholar]
  • 13.Tang CH, Chan GS, Middleton PM, Savkin AV, Lovell NH. Spectral analysis of heart period and pulse transit time derived from electrocardiogram and photoplethysmogram in sepsis patients. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:1781–4. Epub 2009/12/08. 10.1109/IEMBS.2009.5334005 . [DOI] [PubMed] [Google Scholar]
  • 14.Ahmad S, Ramsay T, Huebsch L, Flanagan S, McDiarmid S, Batkin I, et al. Continuous multi-parameter heart rate variability analysis heralds onset of sepsis in adults. PLoS One. 2009;4(8):e6642 Epub 2009/08/15. 10.1371/journal.pone.0006642 ; PubMed Central PMCID: PMC2721415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Barnaby D, Ferrick K, Kaplan DT, Shah S, Bijur P, Gallagher EJ. Heart rate variability in emergency department patients with sepsis. Acad Emerg Med. 2002;9(7):661–70. Epub 2002/07/03. . [DOI] [PubMed] [Google Scholar]
  • 16.Chen WL, Kuo CD. Characteristics of heart rate variability can predict impending septic shock in emergency department patients with sepsis. Acad Emerg Med. 2007;14(5):392–7. Epub 2007/03/29. 10.1197/j.aem.2006.12.015 . [DOI] [PubMed] [Google Scholar]
  • 17.Pontet J, Contreras P, Curbelo A, Medina J, Noveri S, Bentancourt S, et al. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J Crit Care. 2003;18(3):156–63. Epub 2003/11/05. . [DOI] [PubMed] [Google Scholar]
  • 18.de Castilho FM, Ribeiro ALP, da Silva JLP, Nobre V, de Sousa MR. Heart rate variability as predictor of mortality in sepsis: A prospective cohort study. PLoS One. 2017;12(6):e0180060 Epub 2017/06/28. 10.1371/journal.pone.0180060 ; PubMed Central PMCID: PMC5487061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100 Epub 2009/07/22. 10.1371/journal.pmed.1000100 ; PubMed Central PMCID: PMC2707010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Navarese EP, Kozinski M, Pafundi T, Andreotti F, Buffon A, Servi SD, et al. Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology. Cardiol J. 2011;18(1):3–7. Epub 2011/02/10. . [PubMed] [Google Scholar]
  • 21.GA Wells BS, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses: Department of Epidemiology and Community Medicine, University of Ottawa, Canada; [cited 2017 09/25/2017]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. [Google Scholar]
  • 22.Higgins JPT GS, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 2011. Available from: http://handbook-5-1.cochrane.org/.
  • 23.Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13 Epub 2005/04/21. 10.1186/1471-2288-5-13 ; PubMed Central PMCID: PMC1097734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Brown SM, Tate Q, Jones JP, Knox DB, Kuttler KG, Lanspa M, et al. Initial fractal exponent of heart rate variability is associated with success of early resuscitation in patients with severe sepsis or septic shock: a prospective cohort study. J Crit Care. 2013;28(6):959–63. Epub 2013/08/21. 10.1016/j.jcrc.2013.07.050 ; PubMed Central PMCID: PMC3830663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cedillo JL, Arnalich F, Martin-Sanchez C, Quesada A, Rios JJ, Maldifassi MC, et al. Usefulness of alpha7 nicotinic receptor messenger RNA levels in peripheral blood mononuclear cells as a marker for cholinergic antiinflammatory pathway activity in septic patients: results of a pilot study. J Infect Dis. 2015;211(1):146–55. Epub 2014/08/06. 10.1093/infdis/jiu425 . [DOI] [PubMed] [Google Scholar]
  • 26.Chen WL, Chen JH, Huang CC, Kuo CD, Huang CI, Lee LS. Heart rate variability measures as predictors of in-hospital mortality in ED patients with sepsis. Am J Emerg Med. 2008;26(4):395–401. Epub 2008/04/16. 10.1016/j.ajem.2007.06.016 . [DOI] [PubMed] [Google Scholar]
  • 27.Chen WL, Shen YS, Huang CC, Chen JH, Kuo CD. Postresuscitation autonomic nervous modulation after cardiac arrest resembles that of severe sepsis. Am J Emerg Med. 2012;30(1):143–50. Epub 2011/01/07. 10.1016/j.ajem.2010.11.013 . [DOI] [PubMed] [Google Scholar]
  • 28.Gomez Duque M, Enciso Olivera C, Pena Torres E, Segura Duran OD, Nieto Estrada VH. [ECAIS study: inadvertent cardiovascular adverse events in sepsis]. Med Intensiva. 2012;36(5):343–50. Epub 2012/01/06. 10.1016/j.medin.2011.11.008 . [DOI] [PubMed] [Google Scholar]
  • 29.Nogueira AC, Kawabata V, Biselli P, Lins MH, Valeri C, Seckler M, et al. Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability. Shock. 2008;29(3):342–8. Epub 2007/11/15. 10.1097/shk.0b013e31815abbc6 . [DOI] [PubMed] [Google Scholar]
  • 30.Pneumatikos VP, Dragoumanis CD, Pneumatikos IP. Relation of Heart Rate Variability to Serum Levels of C-Reactive Protein in Patients with Severe Sepsis and Septic Shock. Comput Cardiol. 2009;(36):841−4. [DOI] [PubMed] [Google Scholar]
  • 31.Tateishi Y, Oda S, Nakamura M, Watanabe K, Kuwaki T, Moriguchi T, et al. Depressed heart rate variability is associated with high IL-6 blood level and decline in the blood pressure in septic patients. Shock. 2007;28(5):549–53. Epub 2007/12/14. 10.1097/shk.0b013e3180638d1 . [DOI] [PubMed] [Google Scholar]
  • 32.Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–55. Epub 1992/06/01. . [DOI] [PubMed] [Google Scholar]
  • 33.Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250–6. Epub 2003/04/12. 10.1097/01.CCM.0000050454.01978.3B . [DOI] [PubMed] [Google Scholar]
  • 34.Gaykema RP, Dijkstra I, Tilders FJ. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology. 1995;136(10):4717–20. Epub 1995/10/01. 10.1210/endo.136.10.7664696 . [DOI] [PubMed] [Google Scholar]
  • 35.Fleshner M, Goehler LE, Schwartz BA, McGorry M, Martin D, Maier SF, et al. Thermogenic and corticosterone responses to intravenous cytokines (IL-1beta and TNF-alpha) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol. 1998;86(2):134–41. Epub 1998/07/15. . [DOI] [PubMed] [Google Scholar]
  • 36.Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405(6785):458–62. Epub 2000/06/06. 10.1038/35013070 . [DOI] [PubMed] [Google Scholar]
  • 37.Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol. 2008;51(18):1725–33. Epub 2008/05/03. 10.1016/j.jacc.2008.01.038 . [DOI] [PubMed] [Google Scholar]
  • 38.Salo MA, Huikuri HV, Seppanen T. Ectopic beats in heart rate variability analysis: effects of editing on time and frequency domain measures. Ann Noninvasive Electrocardiol. 2001;6(1):5–17. Epub 2001/03/20. . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Peltola MA. Role of editing of R-R intervals in the analysis of heart rate variability. Front Physiol. 2012;3:148 Epub 2012/06/02. 10.3389/fphys.2012.00148 ; PubMed Central PMCID: PMC3358711. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 File. PRISMA checklist.

(DOC)

S2 File. PRISMA flow diagram.

(DOC)

S1 Table. Treatment for artifacts used in each study.

(DOC)

Data Availability Statement

All files are available from the Open Science framework database (https://osf.io/czq6k/).


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES